Teleflex TFX is well-poised to grow in the coming quarters, backed by the performance of its global product category. The acquisition of Palette Life Sciences will bolster the company’s Interventional ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021. TFX stock was trading at around $246 in early ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teleflex, and listening in to earnings ...

Teleflex is up 9.2% since the beginning of the year, and at $133.65 per share, it is trading close to its 52-week high of ...

Looking ahead to 2030, our model projects TFX could trade at an average price of $655.08, with a potential range between $491.31 and $818.85. This represents a potential 417.8% return from today's ...

Teleflex TFX is in the middle of a portfolio reset that is reshaping the company into a more focused medical technology player. Management is working toward closing divestitures while integrating its ...